Notice of System Recovery: System maintenance has been completed. We deeply apologize for the inconvenience caused by exceeding the scheduled completion time.
Product Document Searching Made Easy by 2D Code! | [Product Highlights] Travoprost with Intra-Ocular-...
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 965-52-6 | Product Number: N1181
Nifuroxazide
×
![]()
×
Purity: >98.0%(T)
Synonyms:
- Bacifurane
- 4-Hydroxy-N'-[(5-nitrofuran-2-yl)methylene]benzohydrazide
- (5-Nitro-2-furfurylidene)(4-hydroxybenzoyl)hydrazine
Product Documents:
| Size | Unit Price | Saitama (Kawaguchi) | Hyogo (Amagasaki) | Stock in other WH |
Shipping Information
|
|---|---|---|---|---|---|
| 100MG |
¥3,200
|
26 | It can be shipped from Saitama warehouse on the same day* | Contact Us | |
| 500MG |
¥10,200
|
20 | It can be shipped from Saitama warehouse on the same day* | Contact Us | |
| 5G |
¥64,400
|
34 | It can be shipped from Saitama warehouse on the same day* | Contact Us |
* Available Stock: Prompt shipment (for products) in Saitama/Hyogo warehouse. Stock In Other WH: Shipment in about 2-3 Business Days from Saitama warehouse. Please contact us
if you need further information.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* The displayed price is the unit price and does not include consumption tax. The unit prices displayed are the latest and are subject to change without notice.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | N1181 |
Purity / Analysis Method 
|
>98.0%(T) |
| Molecular Formula / Molecular Weight | C__1__2H__9N__3O__5 = 275.22 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image), 500MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 965-52-6 |
| Reaxys Registry Number | 4264976 |
| PubChem Substance ID | 468592501 |
| Merck Index (14) | 6535 |
| MDL Number | MFCD00079482 |
Specifications
| Appearance | White to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 257 °C(dec.) |
GHS
Related Laws:
| RTECS# | DH2528300 |
Transport Information:
Application
Quorum sensing research
Nifuroxazide showed inhibition of quorum sensing-regulated gene expression and related phenotypes in Pseudomonas aeruginosa in a dose-dependent manner. 1)
References
- 1) Computer-aided identification of recognized drugs as Pseudomonas aeruginosa quorum-sensing inhibitors
Application
Nifuroxazide: An Antibacterial Agent with STAT3 Inhibitory Activity
Nifuroxazide is a broad-spectrum antibacterial agent that has been used for the treatment of infectious diarrhea since 1960’s.1) In 2008, it was discovered that nifuroxazide is a potent inhibitor of the transcription factor STAT3.2) Since then, the potential of nifuroxazide as an anticancer agent has been investigated.3) (The product is for research purpose only.)
References
- 1) In vivo activity of nifurzide and nifuroxazide in intestinal bacteria in man and gnotobiotic mice
- 2) Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- 3) Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment (a review)
- 4) Determination of nifuroxazide and drotaverine hydrochloride in pharmaceutical preparations by three independent analytical methods
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.